Clinical Trials · NCT04525300
Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Xiangya Hospital of Central South University
- Enrollment
- 300
- Start date
- May 2020
- Locations
- 1 site, China
- Primary endpoint
- The composition of the gut microbiota from baseline to end of treatment.